Update information

Update information

May 2016: Recommendation 1.3 in this technology appraisal has been partially updated by recommendation 1.6.2.3 in the NICE guideline on dementia (NICE guideline CG42). Specifically:

  • non-specialists can now prescribe donezepil, galantamine, rivastigmine and memantine, as long as they have taken advice from a clinician who has the necessary knowledge and skills. This includes:

    • secondary care medical specialists such as psychiatrists, geriatricians and neurologists

    • other healthcare professionals such as GPs, nurse consultants and advanced nurse practitioners with specialist expertise in diagnosing and treating Alzheimer's disease

  • local arrangements for prescribing, supply, and treatment review should follow the NICE guideline on medicines optimisation (NICE guideline NG5).

February 2014: implementation section updated to clarify that donepezil, galantamine, rivastigmine and memantine are recommended as an options for treating Alzheimer's disease. Additional minor maintenance update also carried out.

ISBN: 978-1-4731-1898-0

  • National Institute for Health and Care Excellence (NICE)